Raul Santos MD, PhD, MSc, is a preventive cardiologist and lipidologist working at the University of Sao Paulo and Hospital Israelita Albert Einstein in Sao Paulo, Brazil. He is focused on genetic dyslipidemias, imaging in atherosclerosis, non-alcoholic fatty liver disease and novel lipid lowering therapies. He is the immediate past president of the International Atherosclerosis Society and a highly cited researcher in 2021 and 2022 according to Clarivate Analytics.

Dr. Santos reports receiving the following: consulting fees and lecture fees from Abbott, Amgen, Amryt, AstraZeneca, Aché, Biolab, Getz Pharma, Eli-Lilly, Libbs, Merck, PTC Therapeutics, Novo Nordisk, Novartis, Sanofi-Regeneron Pharmaceuticals; grant support from Amgen, Kowa, Esperion, Novartis, Sanofi-Regeneron Pharmaceuticals.